AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 26(3), 1977, pp. 562-563
Copyright © 1977 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clyde, D. F.
Right arrow Articles by McCarthy, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clyde, D. F.
Right arrow Articles by McCarthy, V. C.

Radical Cure of Chesson Strain Vivax Malaria in Man by 7, Not 14, Days of Treatment with Primaquine*

David F. Clyde AND Vincent C. McCarthy
University of Maryland School of Medicine, Baltimore, Maryland 21201

Glucose-6-phosphate dehydrogenase-normal adult volunteers infected with mosquito-borne Chesson strain vivax malaria were treated with chloroquine and primaquine during the initial attack. Administration of 60 mg (base) of primaquine daily for 7 days was as effective in preventing relapse as is the regimen customarily used for the radical cure of infections produced by this strain, namely, 30 mg daily for 14 days. However, it is stressed that because of the risk of primaquine-induced hemolysis in individuals having genetically-transmitted erythrocyte abnormalities this high dosage should not be used routinely.

Accepted for publication January 8, 1977.


* This study was supported by U.S. Army Medical Research and Development Command Contract No. DA-49-193-MD-2740, and is Contribution No. 1434 in the Army Malaria Program.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey
Vivax Malaria: Neglected and Not Benign
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. L. GOLLER, D. JOLLEY, P. RINGWALD, and B.-A. BIGGS
REGIONAL DIFFERENCES IN THE RESPONSE OF PLASMODIUM VIVAX MALARIA TO PRIMAQUINE AS ANTI-RELAPSE THERAPY
Am J Trop Med Hyg, February 1, 2007; 76(2): 203 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
D. R. HILL, J. K. BAIRD, M. E. PARISE, L. S. LEWIS, E. T. RYAN, and A. J. MAGILL
PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I.
Am J Trop Med Hyg, September 1, 2006; 75(3): 402 - 415.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American Society of Tropical Medicine and Hygiene.